ATLANTA, GA / ACCESSWIRE / August 9, 2022 / Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Kiromic BioPharma, Inc. ('Kiromic' or the 'Company') (NASDAQ:KRPB). The lawsuit alleges Kiromic failed to disclose that the FDA imposed a clinical hold for two of its new drug candidates prior to the filing of the Registration Statement and Prospectus, contrary to assurances the Company made to investors.

If you bought shares of Kiromic between June 25, 2021 and August 13, 2021, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm's website at www.holzerlaw.com to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 4, 2022.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

CONTACT:
Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com

SOURCE: Holzer & Holzer